Health Care [ 9/12 ] | Biotechnology [ 61/74 ]
NASDAQ | Common Stock
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase.
The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019.
Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 20, 25 | -0.39 Increased by +45.07% | -0.41 Increased by +3.70% |
| Nov 7, 24 | -0.75 Increased by +13.79% | -0.71 Decreased by -5.63% |
| Aug 1, 24 | -0.70 Increased by +10.26% | -0.74 Increased by +5.41% |
| May 15, 24 | -0.69 Increased by +5.48% | -0.79 Increased by +12.66% |
| Feb 22, 24 | -0.71 Decreased by -33.96% | -0.96 Increased by +26.04% |
| Nov 9, 23 | -0.87 Decreased by -64.15% | -0.81 Decreased by -7.41% |
| Aug 10, 23 | -0.78 Decreased by -20.00% | -0.78 |
| May 11, 23 | -0.73 Decreased by -30.36% | -0.62 Decreased by -17.74% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 0.00 Decreased by -100.00% | -15.00 M Increased by +45.01% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -28.74 M Increased by +12.83% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -26.86 M Increased by +9.25% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -26.34 M Decreased by -1.81% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 1.66 M Increased by +N/A% | -27.29 M Decreased by -6.16% | Decreased by -1.65 K% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -32.97 M Decreased by -102.95% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -29.60 M Decreased by -21.62% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -25.87 M Decreased by -39.29% | Decreased by N/A% Decreased by N/A% |